Evidence map›Paper›PMID 28053643›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats.

Liqin Wang, Yu He, Yuyan Zhang, Huifen Zhou, Li Yu, Jiehong Yang, Haitong Wan

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Experimental Study on the Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liqin WangZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
Yu HeZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
Yuyan ZhangZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
Huifen ZhouZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
Li YuZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.
Jiehong YangZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.ORCID 0000-0002-2758-0485
Haitong WanZhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, Zhejiang 310053, China.ORCID 0000-0001-5726-7214
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypaconitine (HA) and glycyrrhetinic acid (GA) are active components of Fuzi (

Identifiers

PMID28053643
PMCPMC5178377
OpenAlexW2560075150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.